In vitro assays showed that HOXD‐AS2 promoted the TMZ resistance of GBM cells; In vivo animal experiments demonstrated that combination of TMZ and HOXD‐AS2 silencing induced the remarkable DNA damage activity, exhibiting more satisfactory therapeutic effects, simultaneously, the tumor growth was also inhibited significantly. Here, HOXD-AS2 is linked to glioblastoma.